Most Americans in a new poll said they probably won’t get an updated COVID-19 vaccine. The Pew Research Center survey found ...

After decades of disappointment, efforts to create jabs that can stimulate the immune system to fight cancer are showing ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

GEO-CM04S1 Improved Immune Response vs mRNA VaccineATLANTA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology ...

Scott said he has received his COVID booster and flu shot ... explored how the human body responded to mRNA COVID-19 vaccines ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...

The UK has become the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine, paving the way for mass vaccination. Britain's medicines regulator, the MHRA, says the jab, which ...

Fintel reports that on November 18, 2024, HSBC upgraded their outlook for Moderna (NasdaqGS:MRNA) from Hold to Buy. Analyst ...

Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.

Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to ...

1 booster (and Moderna’s, though the TGA has not approved this one at ... Scientists keep updating the COVID vaccines in an effort to keep up with these changes. The better matched the vaccine “spike” ...